In all patients with severe hemorrhage and subsequent
hypovolemic shock, the most important therapy is intravascular
volume resuscitation, to reduce the possibility of target
organ damage and death. Similarly, the current proposals of
transfusion therapy in severe or massive hemorrhage point to
early transfusion of blood products and the use of fresh frozen
plasma, in addition to packed red blood cells, to prevent
consumption coagulopathy